Direxion Daily S&P Biotech Bull 3x Shares Rating $76.85 -1.87 (-2.38%) Closing price 09/15/2025 04:10 PM EasternExtended Trading$77.35 +0.50 (+0.65%) As of 06:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.71Holdings in LABU have an aggregate rating of Moderate Buy based on 411 analyst ratings issued in the past year covering 20 companies (31.1% of the portfolio).LABU Aggregate Price Target$76.85High Prediction$76.85Average Prediction$76.85Low Prediction$76.85Holdings in LABU have an aggregate price target of $76.85 and a range of $76.85 to $76.85 covering 20 companies (31.1% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 20 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.22%ALNYAlnylam Pharmaceuticals$461.14-1.0%3.7903 of 5 stars2.85$421.28 -8.6%27Positive News2.07%INSMInsmed$143.14-1.9%3.3455 of 5 stars2.94$139.86 -2.3%17Positive NewsInsider Trade2.01%UTHRUnited Therapeutics$403.11-0.5%4.7756 of 5 stars2.69$438.85 8.9%13Positive News1.94%HALOHalozyme Therapeutics$76.33-0.7%4.5657 of 5 stars2.33$67.11 -12.1%12Positive News1.71%INCYIncyte$83.14+0.0%4.7357 of 5 stars2.33$82.53 -0.7%18Positive NewsAnalyst DowngradeShort Interest ↓1.60%NBIXNeurocrine Biosciences$140.44-1.0%4.7589 of 5 stars2.85$160.26 14.1%20Positive News1.57%MDGLMadrigal Pharmaceuticals$425.60-1.5%4.2692 of 5 stars2.90$483.38 13.6%101.51%BBIOBridgeBio Pharma$51.47+0.5%4.4178 of 5 stars3.00$63.94 24.2%17Analyst Forecast1.51%ABBVAbbVie$217.92-0.2%4.7651 of 5 stars2.92$218.76 0.4%26Trending NewsAnalyst ForecastAnalyst Revision1.48%REGNRegeneron Pharmaceuticals$572.59+2.2%4.7091 of 5 stars2.82$817.67 42.8%28Positive NewsShort Interest ↑1.48%BIIBBiogen$143.32-1.1%4.6921 of 5 stars2.32$181.65 26.7%31Positive News1.46%GILDGilead Sciences$112.54-1.8%4.9236 of 5 stars2.89$115.39 2.5%27Positive News1.45%NTRANatera$172.16+2.2%3.5278 of 5 stars3.06$194.00 12.7%18Positive News1.37%EXASExact Sciences$53.43-0.9%4.7753 of 5 stars2.88$68.05 27.4%24Positive NewsShort Interest ↓Analyst Revision1.34%BMRNBioMarin Pharmaceutical$53.14-1.8%4.9748 of 5 stars2.69$92.04 73.2%26Positive NewsAnalyst UpgradeShort Interest ↑1.33%IONSIonis Pharmaceuticals$61.10-3.3%3.8026 of 5 stars2.81$67.88 11.1%161.32%AMGNAmgen$274.40-0.7%4.6508 of 5 stars2.24$304.43 10.9%21Positive News1.27%EXELExelixis$39.01-0.4%4.6942 of 5 stars2.52$44.06 12.9%23Positive NewsAnalyst Downgrade1.25%CYTKCytokinetics$49.44-3.3%4.3881 of 5 stars2.87$75.38 52.5%15Positive NewsInsider Trade1.21%MRNAModerna$23.88+1.6%4.4726 of 5 stars2.05$41.81 75.1%22 This page (NYSEARCA:LABU) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
